Iris Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 Cr
- Satisfied Charges ₹ 6.34 Cr
- Revenue Growth 21.57%
- Profit Growth 168.79%
- Ebitda -27.36%
- Net Worth 2.91%
- Total Assets 9.67%
About Iris Biotech
Iris Biotech Private Limited (IBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 August 2003 and has a history of 21 years and five months. Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.20 Cr. The company has closed loans amounting to ₹6.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkatarao Kopuru and Chandana Kopuru serve as directors at the Company.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74130KA2003PTC032443
-
Company No.
032443
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Aug 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Iris Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatarao Kopuru
|
Director | 27-Aug-2003 | Current |
|
Chandana Kopuru
|
Whole-Time Director | 23-Feb-2022 | Current |
Financial Performance of Iris Biotech.
Iris Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.57% increase. The company also saw a substantial improvement in profitability, with a 168.79% increase in profit. The company's net worth moved up by a moderate rise of 2.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iris Biotech?
Unlock access to Iris Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.20 Cr
₹6.34 Cr
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2022 | City Union Bank Limited | ₹7.50 M | Open |
| 31 Aug 2017 | City Union Bank Limited | ₹4.50 M | Open |
| 31 Aug 2017 | City Union Bank Limited | ₹1.05 Cr | Satisfied |
| 30 Sep 2015 | City Union Bank Limited | ₹4.20 M | Satisfied |
| 29 Aug 2015 | City Union Bank Limited | ₹2.22 M | Satisfied |
How Many Employees Work at Iris Biotech?
Unlock and access historical data on people associated with Iris Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iris Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iris Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
